Primary Adrenal Lymphoma with Secondary Central Nervous System Involvement: A Case Report and Review of the Literature

被引：5

作者：

Aydin, Kubra ^{[1
]}

Okutur, Kerem ^{[1
]}

Bozkurt, Mustafa ^{[1
]}

Aydin, Ozlem ^{[3
]}

Namal, Esat ^{[1
]}

Ozturk, Akin ^{[1
]}

Pilanci, Kezban Nur ^{[1
]}

Kucukkaya, Reyhan Diz ^{[2
]}

Demir, Osman Gokhan ^{[1
]}

机构：

[1] Istanbul Bilim Univ, Dept Internal Med, Div Med Oncol, Istanbul, Turkey

[2] Istanbul Bilim Univ, Dept Internal Med, Div Hematol, Istanbul, Turkey

[3] Acibadem Univ, Sch Med, Dept Pathol, Istanbul, Turkey

来源：

TURKISH JOURNAL OF HEMATOLOGY | 2013年 / 30卷 / 04期

关键词：

Primary adrenal lymphoma; Central nervous system involvement; NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; CNS INVOLVEMENT; PROGNOSTIC-FACTORS; ADDISONS-DISEASE; CHEMOTHERAPY; RECURRENCE; RISK;

D O I：

10.4274/Tjh.2012.0172

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Approximately 10%-20% of all systemic lymphomas have central nervous system (CNS) involvement, which has been correlated to a worsened prognosis. It is well known that secondary involvement of the adrenal glands may occur in up to 25% of patients during the course of diffuse lymphoma. Primary adrenal lymphoma (PAL), however, is a different entity, and it is defined as the presence of adrenal lymphoma without evidence of either nodal involvement or leukemia. It has been shown that this occurrence is rarely accompanied by extranodal involvement, such as in the CNS. PAL exhibits a tendency for CNS relapse and this possibility should be examined even before symptoms are present. Herein we present a patient with PAL and secondary CNS involvement.

引用

页码：405 / 408

页数：4

共 19 条

[1] Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma [J].

Abramson, Jeremy S. ;

Hellmann, Matthew ;

Barnes, Jeffrey A. ;

Hammerman, Peter ;

Toomey, Christiana ;

Takvorian, Tak ;

Muzikansky, Alona ;

Hochberg, Ephraim P. .

CANCER, 2010, 116 (18) :4283-4290

[2] How I treat patients with diffuse large B-cell lymphorna [J].

Armitage, James O. .

BLOOD, 2007, 110 (01) :29-36

[3] Primary central nervous system lymphoma [J].

Ferreri, Andres J. M. ;

Reni, Michele .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (03) :257-268

[4] A case of primary bilateral adrenal lymphoma (PAL) with central nervous system (CNS) involvement [J].

Hahn, JS ;

Choi, HS ;

Suh, CO ;

Lee, WJ .

YONSEI MEDICAL JOURNAL, 2002, 43 (03) :385-390

[5] Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis [J].

Hollender, A ;

Kvaloy, S ;

Lote, K ;

Nome, O ;

Holte, H .

EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1762-1768

[6] Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) [J].

Kim, Yu Ri ;

Kim, Jin Seok ;

Min, Yoo Hong ;

HyunYoon, Dok ;

Shin, Ho-Jin ;

Mun, Yeung-Chul ;

Park, Yong ;

Do, Young Rok ;

Jeong, Seong Hyun ;

Park, Joon Seong ;

Oh, Sung Yong ;

Lee, Suee ;

Park, Eun Kyung ;

Jang, Joung-Soon ;

Lee, Won-Sik ;

Lee, Hwe-Won ;

Eom, HyeonSeok ;

Ahn, Jae-sook ;

Jeong, Jae-Heon ;

Baek, Sun Kyung ;

Kim, Seok Jin ;

Kim, Won Seog ;

Suh, Cheolwon .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5

[7] Primary Adrenal Lymphoma presenting as Addison's disease. Case report and review of the literature [J].

Kita, M. ;

Mandala, E. ;

Saratzis, A. ;

Ventzi, L. ;

Venizelos, I. ;

Keryttopoulous, P. ;

Efstathiadou, Z. ;

Garyfallos, A. ;

Avramides, A. .

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (06) :363-365

[8]

Kunavisarut Tada, 2009, Journal of the Medical Association of Thailand, V92, P687

[9]

LEVITT LJ, 1980, CANCER-AM CANCER SOC, V45, P545, DOI 10.1002/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO

[10]

2-6

← 1 2 →